NYSE$CVSA

Covista Inc · Q1 2025 earnings

Q1 2025 earnings · · Investor relations

Briefing

Adtalem's first quarter of fiscal year 2025 results were reported, with revenue and adjusted EPS exceeding expectations, leading to raised guidance.

Adtalem Global Education reported a strong first quarter for fiscal year 2025, with revenue up 13.2% year-over-year to $417.4 million and diluted earnings per share at $1.18. Adjusted EPS grew 38.7% year-over-year to $1.29. The company raised its fiscal year 2025 revenue guidance to $1,690 million to $1,730 million and adjusted EPS guidance to $5.75 to $5.95.

  • Total student enrollment increased 11.2% year-over-year to 90,140.
  • Revenue increased 13.2% year-over-year to $417.4 million.
  • Chamberlain University experienced its seventh consecutive quarter of enrollment growth, up 11.7% year-over-year.
  • Walden University saw its fifth straight quarter of enrollment growth, up 12.2% year-over-year.

Headline financials

Total Revenue

$417M

Previous: $369M+13.2%
EPS

$1.18

Previous: $0.93+26.9%
Total Students

90.1K

No prior period
Chamberlain Total Students

39.0K

No prior period
Walden Total Students

46.0K

No prior period
Medical and Veterinary Total Students

5.2K

No prior period
Adjusted EBITDA

$96.7M

No prior period
Adjusted EBITDA Margin

23.2%

No prior period
Capital Expenditures

-$10.4M

Previous: -$15M+30.8%
Free Cash Flow

$35.8M

Previous: -$4.4M+912.5%
Net Income

$46.2M

Previous: $10.6M+333.6%
Operating Income

$70.2M

Previous: $28.2M+149.1%
Gross Profit

$231M

Previous: $200M+15.6%
Cash & Equivalents

$265M

Previous: $262M+0.9%
Total Assets

$2.82B

Previous: $2.79B+0.8%
Stock-Based Comp

$9.45M

Previous: $7.46M+26.8%

Revenue & EPS history

Adtalem · Revenue · Quarterly

$417M

Q1 2025+13.2%vs Q1 2024
Beat estimate in 12 of 14 quarters(86%)
ActualEstimate

Revenue by segment

Adtalem · $369M total across 3 segments · Q1 2024

  • Chamberlain
    $143M+5.3%
  • Walden
    $142M+8.2%
  • Medical and Veterinary
    $84.6M-4.1%

Forward guidance

Adtalem raises guidance for fiscal year 2025, with revenue in the range of $1,690 million to $1,730 million, approximately 6.5% to 9.0% growth year-over-year. Adjusted earnings per share to be in the range of $5.75 to $5.95, approximately 14.5% to 18.5% growth year-over-year.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

-0.7%

Avg return

Earnings day

-0.3%

Avg return

5 days after

+0.7%

Avg return

30 days after

43%

29 / 67 earnings

Positive

+22.8%

Q1 2013

Best reaction

-33.2%

Q1 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026+13.2%+10.2%+8.0%
Q2 2026-7.8%-14.2%-15.5%
Q1 2026-33.2%-31.2%-34.7%
Q3 2025+16.4%+11.9%+10.7%
Q2 2025+4.6%+7.5%-0.1%
Q1 2025+12.0%+8.7%+23.8%
Q4 2024-7.3%-2.1%-2.2%
Q3 2024+18.9%+24.8%+27.5%
Q2 2024-13.9%-17.5%-15.6%
Q1 2024+12.5%+16.6%+29.4%
Q4 2023-1.1%-4.0%-0.8%
Q3 2023+4.5%+2.0%+2.4%
Q2 2023+13.7%+3.1%+2.2%
Q1 2023+2.4%+6.9%-2.1%
Q4 2022-3.1%-2.6%-2.8%
Q3 2022+6.4%+10.9%+17.5%
Q2 2022-12.7%-16.0%-15.2%
Q1 2022-12.9%-6.0%-16.6%
Q4 2021+1.3%+0.3%+11.8%
Q3 2021-6.9%-8.3%-1.3%
Q2 2021+0.1%+0.9%-2.8%
Q1 2021+3.7%+11.0%+16.6%
Q4 2020-4.4%-6.5%-25.9%
Q3 2020+3.7%+9.8%+11.5%
Q2 2020+3.1%-3.0%-14.9%
Q1 2020-19.2%-16.8%-7.8%
Q4 2019-12.5%-14.6%-20.9%
Q3 2019-7.6%-9.0%-11.4%
Q2 2019-3.3%-3.6%-4.1%
Q1 2019+4.3%+10.7%+14.0%
Q4 2018-15.8%-13.5%-20.0%
Q3 2018-5.7%-3.0%+1.4%
Q2 2018+7.1%+3.7%+12.3%
Q1 2018-2.7%+1.1%+9.7%
Q4 2017+4.3%+4.0%+8.1%
Q3 2017-0.8%+5.0%+0.5%
Q2 2017-0.5%-3.0%+0.2%
Q1 2017+1.8%+1.5%+31.5%
Q4 2016+17.7%+11.8%+4.3%
Q3 2016+17.3%
Q2 2016-14.2%
Q1 2016-2.3%
Q4 2015-7.7%
Q3 2015-15.9%
Q2 2015-17.9%
Q1 2015+0.8%
Q4 2014-3.2%
Q3 2014+13.0%
Q2 2014-2.6%
Q1 2014+6.2%
Q4 2013-9.5%
Q3 2013-17.6%
Q2 2013+19.1%
Q1 2013+22.8%
Q4 2009-2.2%
Q4 2012-2.3%
Q3 2012-0.4%
Q2 2012-8.5%
Q1 2012-0.8%
Q4 2011+4.7%
Q3 2011-1.4%
Q3 2010-1.4%
Q2 2010+0.0%
Q2 2011+0.0%
Q4 2010-1.1%
Q1 2010-1.1%
Q1 2011-1.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro